Page last updated: 2024-08-24

geranylgeraniol and B16 Melanoma

geranylgeraniol has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dutta, D; Elfakhani, M; Fernandes, NV; Hynds, DL; Katuru, R; King, C; Mills, N; Mo, H	1

Other Studies

1 other study(ies) available for geranylgeraniol and B16 Melanoma

Article	Year
Mevalonate depletion mediates the suppressive impact of geranylgeraniol on murine B16 melanoma cells. Experimental biology and medicine (Maywood, N.J.), 2011, May-01, Volume: 236, Issue:5 Topics: 3T3-L1 Cells; Alkaline Phosphatase; Animals; Apoptosis; Cell Cycle; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 4; Diterpenes; Humans; Lovastatin; Melanoma, Experimental; Mevalonic Acid; Mice; Vitamin E	2011

Article

Year

Mevalonate depletion mediates the suppressive impact of geranylgeraniol on murine B16 melanoma cells.

Experimental biology and medicine (Maywood, N.J.), 2011, May-01, Volume: 236, Issue:5

Topics: 3T3-L1 Cells; Alkaline Phosphatase; Animals; Apoptosis; Cell Cycle; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 4; Diterpenes; Humans; Lovastatin; Melanoma, Experimental; Mevalonic Acid; Mice; Vitamin E

2011